Completed PHASE2 INTERVENTIONAL NCT00000613

CVD Risk and Health in Postmenopausal Phytoestrogen Users

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Conditions Bone Diseases Cardiovascular Diseases Coronary Disease Depression Heart Diseases Myocardial Ischemia Osteoporosis Postmenopause

Interventions diet, soy proteins dietary supplements genistein

Updated 5 times since 2017 Last updated: Feb 26, 2016 Started: Apr 30, 1997 Completion: Dec 31, 2004

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Bone Diseases and Cardiovascular Diseases, this trial is completed. The trial is conducted by National Heart, Lung, and Blood Institute (NHLBI) and has accumulated 5 data snapshots since 1997. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Apr 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Heart, Lung, and Blood Institute (NHLBI)

Data source: National Heart, Lung, and Blood Institute (NHLBI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.